Mikaël Daouphars
Mikaël Daouphars is an expert in Pharmacy at Centre Henri Becquerel (France). Mikaël Daouphars has authored 33 publications, the most recent in 2025. SLR score: 68 (community average: 125). How the SLR is computed.
LeadR Profile
Pharmacy
Subspecialties:
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2012 - 2025
Number : 33
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Concordance between Tympanic and Enteral Temperature for Early Fever Detection in Hematologic Intensive Care Unit Patients: A Prospective Study. PMID 40262543 — research design, hematology, ear, capsules, intensive care units, temperature, prospective studies | Acta Haematol | 2025 | 0 |
| Cost effectiveness of using trastuzumab biosimilars compared to trastuzumab original drugs to treat breast cancer in a hospital setting. PMID 37857129 — diagnosis-related groups, breast diseases, pharmaceutical preparations, breast neoplasms, prescriptions, cost-benefit analysis, cost savings, biosimilar pharmaceuticals, trastuzumab | Breast | 2023 | 0 |
| Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines). PMID 32623296 — coronavirus, safety, oncologists, pharmaceutical preparations, antineoplastic agents, neoplasms, pharmacists, pharmacy, covid-19, pandemics, therapeutics | Cancer Treat Rev | 2020 | 39 |
| Physicochemical stability of oxycodone-ketamine solutions in polypropylene syringe and polyvinyl chloride bag for patient-controlled analgesia use. PMID 31157023 — oxycodone, syringes, ketamine, polyvinyl chloride, solutions, polyvinyls, polypropylenes, analgesia, patient-controlled | Eur J Hosp Pharm | 2016 | 7 |
| Development of a 'ready-to-use' tool that includes preventability, for the assessment of adverse drug events in oncology. PMID 29446003 — pharmaceutical preparations, neoplasms, drug therapy, drug-related side effects and adverse reactions | Int J Clin Pharm | 2018 | 4 |
LeadR Networks
Main global connection map